Angina Market: How Are Novel Antianginal Therapies Reshaping...

a adăugat un sunet Health

2026-05-13 10:37:21 -

Angina Market: How Are Novel Antianginal Therapies Reshaping Treatment Beyond Traditional Beta-Blockers?

The evolution of antianginal pharmacotherapy — the development and commercial positioning of novel mechanisms including the If channel inhibitor ivabradine, the late sodium current inhibitor ranolazine, and the emerging soluble guanylate cyclase stimulator vericiguat creating clinical alternatives for patients with inadequate symptom control on conventional therapy — redefines the...

0 Commentarii 0 Distribuiri 43 Views 0 previzualizare